However, about half of the DLBCL from the identified the high risk group did not harbor gene rearrangements of MYC and BCL2, suggesting the existence of alternative genetic or epigenetic alterations causing a high-grade lymphoma phenotype. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.